Zhongjie has completed his postdoctoral research and left our group to take up a new role. During his time here, he made outstanding contributions to the development of the membrane-aware anisotropic network model (MCP-ANM). He has joined Beijing Sun-Novo Pharmaceutical Research Co., Ltd. as a director of innovative drug research. We wish him every success in his future career.